{"SLR NAME":"Comparison of the cardiovascular presentations, complications and outcomes following different corona viruses’ infection, a systematic review","References":[{"title1":"Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)","References":[{"title2":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","References":[{"title3":"Outbreak%20of%20pneumonia%20of%20unknown%20etiology%20in%20Wuhan,%20China:%20the%20mystery%20and%20the%20miracle"},{"title3":"Outbreak%20of%20pneumonia%20of%20unknown%20etiology%20in%20Wuhan,%20China:%20the%20mystery%20and%20the%20miracle"},{"title3":"Outbreak%20of%20pneumonia%20of%20unknown%20etiology%20in%20Wuhan,%20China:%20the%20mystery%20and%20the%20miracle"},{"title3":"Outbreak%20of%20pneumonia%20of%20unknown%20etiology%20in%20Wuhan,%20China:%20the%20mystery%20and%20the%20miracle"},{"title3":"Outbreak%20of%20pneumonia%20of%20unknown%20etiology%20in%20Wuhan,%20China:%20the%20mystery%20and%20the%20miracle"},{"title3":"Outbreak%20of%20pneumonia%20of%20unknown%20etiology%20in%20Wuhan,%20China:%20the%20mystery%20and%20the%20miracle"},{"title3":"Outbreak%20of%20pneumonia%20of%20unknown%20etiology%20in%20Wuhan,%20China:%20the%20mystery%20and%20the%20miracle"},{"title3":"Outbreak%20of%20pneumonia%20of%20unknown%20etiology%20in%20Wuhan,%20China:%20the%20mystery%20and%20the%20miracle"},{"title3":"Outbreak%20of%20pneumonia%20of%20unknown%20etiology%20in%20Wuhan,%20China:%20the%20mystery%20and%20the%20miracle"}]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China","References":[{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health:%20the%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China"},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health:%20the%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China"},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health:%20the%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China"},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health:%20the%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China"},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health:%20the%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China"}]},{"title2":"Coronavirus infections: more than just the common cold","References":[]},{"title2":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected","References":[]},{"title2":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","References":[{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"},{"title3":"SARS-coronavirus%20modulation%20of%20myocardial%20ACE2%20expression%20and%20inflammation%20in%20patients%20with%20SARS"}]},{"title2":"A Novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20Novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"}]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"},{"title3":"Evolution%20of%20the%20novel%20coronavirus%20from%20the%20ongoing%20Wuhan%20outbreak%20and%20modeling%20of%20its%20spike%20protein%20for%20risk%20of%20human%20transmission"}]},{"title2":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia","References":[]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","References":[{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"},{"title3":"A%20crucial%20role%20of%20angiotensin%20converting%20enzyme%202%20(ACE2)%20in%20SARS%20coronavirus-induced%20lung%20injury"}]}]},{"title1":"Clinical features and treatment of COVID?19 patients in northeast Chongqing","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"  . Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. World Health Organization. 2020.","References":[]},{"title2":"Diagnosis and treatment of novel coronavirus pneumonia (trial version 5)","References":[]},{"title2":"Effects of matrine combied with baicalin on mouse pneumonia induced by LPS","References":[]},{"title2":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","References":[]},{"title2":"Clinical characteristics of 2019 novel coronavirus infection in China","References":[{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"},{"title3":"Clinical%20characteristics%20of%202019%20novel%20coronavirus%20infection%20in%20China"}]},{"title2":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","References":[{"title3":"Importation%20and%20human-to-human%20transmission%20of%20a%20novel%20coronavirus%20in%20Vietnam"},{"title3":"Importation%20and%20human-to-human%20transmission%20of%20a%20novel%20coronavirus%20in%20Vietnam"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period","References":[]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"},{"title3":"Epidemiological,%20demographic,%20and%20clinical%20characteristics%20of%2047%20cases%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus%20disease%20from%20Saudi%20Arabia:%20a%20descriptive%20study"}]},{"title2":"Severe acute respiratory syndrome: radiographic and CT findings","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)","References":[]},{"title2":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures","References":[{"title3":"The%20first%20case%20of%202019%20novel%20coronavirus%20pneumonia%20imported%20into%20Korea%20from%20Wuhan,%20China:%20implication%20for%20infection%20prevention%20and%20control%20measures"},{"title3":"The%20first%20case%20of%202019%20novel%20coronavirus%20pneumonia%20imported%20into%20Korea%20from%20Wuhan,%20China:%20implication%20for%20infection%20prevention%20and%20control%20measures"},{"title3":"The%20first%20case%20of%202019%20novel%20coronavirus%20pneumonia%20imported%20into%20Korea%20from%20Wuhan,%20China:%20implication%20for%20infection%20prevention%20and%20control%20measures"},{"title3":"The%20first%20case%20of%202019%20novel%20coronavirus%20pneumonia%20imported%20into%20Korea%20from%20Wuhan,%20China:%20implication%20for%20infection%20prevention%20and%20control%20measures"},{"title3":"The%20first%20case%20of%202019%20novel%20coronavirus%20pneumonia%20imported%20into%20Korea%20from%20Wuhan,%20China:%20implication%20for%20infection%20prevention%20and%20control%20measures"},{"title3":"The%20first%20case%20of%202019%20novel%20coronavirus%20pneumonia%20imported%20into%20Korea%20from%20Wuhan,%20China:%20implication%20for%20infection%20prevention%20and%20control%20measures"},{"title3":"The%20first%20case%20of%202019%20novel%20coronavirus%20pneumonia%20imported%20into%20Korea%20from%20Wuhan,%20China:%20implication%20for%20infection%20prevention%20and%20control%20measures"},{"title3":"The%20first%20case%20of%202019%20novel%20coronavirus%20pneumonia%20imported%20into%20Korea%20from%20Wuhan,%20China:%20implication%20for%20infection%20prevention%20and%20control%20measures"}]},{"title2":"Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR","References":[{"title3":"Case%20of%20the%20index%20patient%20who%20caused%20tertiary%20transmission%20of%20COVID-19%20infection%20in%20Korea:%20the%20application%20of%20lopinavir/ritonavir%20for%20the%20treatment%20of%20COVID-19%20infected%20pneumonia%20monitored%20by%20quantitative%20RT-PCR"},{"title3":"Case%20of%20the%20index%20patient%20who%20caused%20tertiary%20transmission%20of%20COVID-19%20infection%20in%20Korea:%20the%20application%20of%20lopinavir/ritonavir%20for%20the%20treatment%20of%20COVID-19%20infected%20pneumonia%20monitored%20by%20quantitative%20RT-PCR"},{"title3":"Case%20of%20the%20index%20patient%20who%20caused%20tertiary%20transmission%20of%20COVID-19%20infection%20in%20Korea:%20the%20application%20of%20lopinavir/ritonavir%20for%20the%20treatment%20of%20COVID-19%20infected%20pneumonia%20monitored%20by%20quantitative%20RT-PCR"},{"title3":"Case%20of%20the%20index%20patient%20who%20caused%20tertiary%20transmission%20of%20COVID-19%20infection%20in%20Korea:%20the%20application%20of%20lopinavir/ritonavir%20for%20the%20treatment%20of%20COVID-19%20infected%20pneumonia%20monitored%20by%20quantitative%20RT-PCR"},{"title3":"Case%20of%20the%20index%20patient%20who%20caused%20tertiary%20transmission%20of%20COVID-19%20infection%20in%20Korea:%20the%20application%20of%20lopinavir/ritonavir%20for%20the%20treatment%20of%20COVID-19%20infected%20pneumonia%20monitored%20by%20quantitative%20RT-PCR"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"},{"title3":"Expression%20of%20elevated%20levels%20of%20pro-inflammatory%20cytokines%20in%20SARS-CoV-infected%20ACE2+%20cells%20in%20SARS%20patients:%20relation%20to%20the%20acute%20lung%20injury%20and%20pathogenesis%20of%20SARS"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"},{"title3":"Plasma%20inflammatory%20cytokines%20and%20chemokines%20in%20severe%20acute%20respiratory%20syndrome"}]},{"title2":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","References":[{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"},{"title3":"Treatment%20with%20interferon-alpha2b%20and%20ribavirin%20improves%20outcome%20in%20MERS-CoV-infected%20rhesus%20macaques"}]},{"title2":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","References":[{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"},{"title3":"Distinct%20immune%20response%20in%20two%20MERS-CoV-infected%20patients:%20can%20we%20go%20from%20bench%20to%20bedside?"}]},{"title2":"On the use of corticosteroids for 2019-nCoV pneumonia","References":[{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia"},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia"},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia"},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia"},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia"},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia"},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia"},{"title3":"On%20the%20use%20of%20corticosteroids%20for%202019-nCoV%20pneumonia"}]},{"title2":"SARS: systematic review of treatment effects","References":[{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"},{"title3":"SARS:%20systematic%20review%20of%20treatment%20effects"}]},{"title2":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience","References":[{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"},{"title3":"Treatment%20of%20severe%20acute%20respiratory%20syndrome%20with%20glucosteroids:%20the%20Guangzhou%20experience"}]},{"title2":"Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia","References":[]},{"title2":"Application of Chinese medicine in acute and critical medical conditions","References":[]}]},{"title1":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title2":"The novel coronavirus originating in Wuhan, China: challenges for global health governance","References":[]},{"title2":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group","References":[]},{"title2":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)","References":[]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Chinese management guideline for COVID-19 (version 6.0)","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"}]},{"title2":"Middle East respiratory syndrome","References":[]},{"title2":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Predictors of mortality in Middle East respiratory syndrome (MERS)","References":[{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"},{"title3":"Predictors%20of%20mortality%20in%20Middle%20East%20respiratory%20syndrome%20(MERS)"}]},{"title2":"Exacerbated innate host response to SARS-CoV in aged non-human primates","References":[{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"},{"title3":"Exacerbated%20innate%20host%20response%20to%20SARS-CoV%20in%20aged%20non-human%20primates"}]},{"title2":"The immunopathogenesis of sepsis in elderly patients","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"},{"title3":"The%20Third%20International%20Consensus%20Definitions%20for%20Sepsis%20and%20Septic%20Shock%20(Sepsis-3)"}]},{"title2":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","References":[]},{"title2":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network","References":[]},{"title2":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study","References":[]},{"title2":"Acute pneumonia and the cardiovascular system","References":[]},{"title2":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","References":[]},{"title2":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015","References":[{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"},{"title3":"Laboratory-confirmed%20respiratory%20infections%20as%20predictors%20of%20hospital%20admission%20for%20myocardial%20infarction%20and%20stroke:%20time-series%20analysis%20of%20English%20data%20for%202004-2015"}]},{"title2":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia","References":[]},{"title2":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis","References":[]},{"title2":"Risk of myocardial infarction and stroke after acute infection or vaccination","References":[]},{"title2":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality","References":[]},{"title2":"Cardiovascular complications of acute respiratory infections: current research and future directions","References":[]},{"title2":"Regulation of ACE2 in cardiac myocytes and fibroblasts","References":[]},{"title2":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"},{"title3":"Pathological%20findings%20of%20COVID-19%20associated%20with%20acute%20respiratory%20distress%20syndrome"}]},{"title2":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase","References":[{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"},{"title3":"Persistent%20shedding%20of%20viable%20SARS-CoV%20in%20urine%20and%20stool%20of%20SARS%20patients%20during%20the%20convalescent%20phase"}]},{"title2":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection","References":[]},{"title2":"Viral load kinetics of MERS coronavirus infection","References":[]},{"title2":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection","References":[{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"},{"title3":"Factors%20associated%20with%20prolonged%20viral%20shedding%20in%20patients%20with%20avian%20influenza%20A(H7N9)%20virus%20infection"}]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"}]}]},{"title1":"Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Novel Wuhan (2019-nCoV) coronavirus","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features","References":[{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"},{"title3":"Severe%20acute%20respiratory%20syndrome:%20historical,%20epidemiologic,%20and%20clinical%20features"}]},{"title2":"The Middle East Respiratory Syndrome (MERS)","References":[]},{"title2":"A new coronavirus associated with human respiratory disease in China","References":[]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"},{"title3":"Clinical%20course%20and%20risk%20factors%20for%20mortality%20of%20adult%20inpatients%20with%20COVID-19%20in%20Wuhan,%20China:%20a%20retrospective%20cohort%20study"}]},{"title2":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","References":[]},{"title2":"A major outbreak of severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area","References":[]},{"title2":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","References":[]},{"title2":"Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation","References":[]},{"title2":"Mechanisms of eosinophil-associated inflammation","References":[]},{"title2":"30 day mortality and eosinopenia in patients with pneumonia","References":[]},{"title2":"Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen","References":[]},{"title2":"IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection","References":[]},{"title2":"CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness","References":[]},{"title2":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","References":[{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"},{"title3":"Clinical%20and%20biochemical%20indexes%20from%202019-nCoV%20infected%20patients%20linked%20to%20viral%20loads%20and%20lung%20injury"}]},{"title2":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Radiological%20findings%20from%2081%20patients%20with%20COVID-19%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily","References":[]}]},{"title1":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","References":[{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"},{"title3":"Clinical%20course%20and%20outcomes%20of%20critically%20ill%20patients%20with%20SARS-CoV-2%20pneumonia%20in%20Wuhan,%20China:%20a%20single-centered,%20retrospective,%20observational%20study"}]},{"title2":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus","References":[]},{"title2":"Comprehensive myocardial proteogenomics profiling reveals C/EBPalpha as the key factor in the lipid storage of ARVC","References":[]},{"title2":"Detection of SARS-CoV-2 in different types of clinical specimens","References":[{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"}]},{"title2":"The Angiopoietin ligands and Tie receptors: potential diagnostic biomarkers of vascular disease","References":[]}]}]}